JSKN-016-HC

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameJSKN-016-HC

Drug Alias NameJSKN-016-HC

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 modulatorsTumor-associated calcium signal transducer 2 modulatorsDNA topoisomerase I inhibitors

TargetsTumor-associated calcium signal transducer 2DNA topoisomerase IReceptor tyrosine-protein kinase erbB-3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJiangsu Alphamab Biopharmaceuticals Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Alphamab Biopharmaceuticals Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A